CV Sciences, Inc. (CVSI)
0.02
0.00 (0.00%)
USD |
OTCM |
Sep 01, 16:00
CV Sciences Enterprise Value : 5.249M for Sept. 1, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 01, 2026 | 5.249M |
| August 31, 2026 | 4.972M |
| August 28, 2026 | 4.960M |
| August 27, 2026 | 4.331M |
| August 26, 2026 | 4.666M |
| August 25, 2026 | 4.801M |
| August 24, 2026 | 4.951M |
| August 21, 2026 | 5.228M |
| August 20, 2026 | 5.143M |
| August 19, 2026 | 5.249M |
| August 18, 2026 | 5.194M |
| August 17, 2026 | 5.203M |
| August 14, 2026 | 6.315M |
| August 13, 2026 | 6.390M |
| August 12, 2026 | 5.782M |
| August 11, 2026 | 5.974M |
| August 10, 2026 | 6.059M |
| August 07, 2026 | 5.480M |
| August 06, 2026 | 5.463M |
| August 05, 2026 | 6.145M |
| August 04, 2026 | 6.507M |
| August 03, 2026 | 5.036M |
| July 31, 2026 | 5.239M |
| July 30, 2026 | 5.207M |
| July 29, 2026 | 5.356M |
| Date | Value |
|---|---|
| July 28, 2026 | 5.249M |
| July 27, 2026 | 5.181M |
| July 24, 2026 | 5.889M |
| July 23, 2026 | 5.654M |
| July 22, 2026 | 5.350M |
| July 21, 2026 | 5.207M |
| July 20, 2026 | 4.823M |
| July 17, 2026 | 5.249M |
| July 16, 2026 | 5.356M |
| July 15, 2026 | 5.070M |
| July 14, 2026 | 5.494M |
| July 13, 2026 | 5.686M |
| July 10, 2026 | 5.821M |
| July 09, 2026 | 5.676M |
| July 08, 2026 | 5.463M |
| July 07, 2026 | 5.569M |
| July 06, 2026 | 5.292M |
| July 02, 2026 | 6.102M |
| July 01, 2026 | 6.187M |
| June 30, 2026 | 6.166M |
| June 29, 2026 | 5.437M |
| June 26, 2026 | 5.824M |
| June 25, 2026 | 5.437M |
| June 24, 2026 | 5.437M |
| June 23, 2026 | 5.200M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Cyanotech Corp. | 13.32M |
| Mannatech, Inc. | 14.16M |
| Natural Alternatives International, Inc. | 68.96M |
| USANA Health Sciences, Inc. | 133.85M |
| Nature's Sunshine Products, Inc. | 183.23M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.775M |
| Revenue (Quarterly) | 2.985M |
| Total Expenses (Quarterly) | 3.76M |
| EPS Diluted (Quarterly) | -0.0038 |
| Gross Profit Margin (Quarterly) | 48.58% |
| Profit Margin (Quarterly) | -25.96% |
| Earnings Yield | -52.00% |
| Normalized Earnings Yield | -39.50 |